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ABSTRACT 
Leukocyte adhesion deficiency (LAD) is an autosomal recessive disease caused by a defective CD18 gene. The 
cell-surface glycoprotein encoded by this gene C D 1 8 is normally expressed in cells of the hematopoietic system. 
A n in vitro murine model of C D 1 8 gene replacement therapy was developed to investigate the feasibility of an in 
vivo murine hematopoietic stem cell gene therapy model. H u m a n CD18-transducing retroviruses were used to 
transfer a functional h u m a n C D 1 8 gene into a variety of cells including (i) murine lymphoblasts (which express 
murine C D l l a and murine CD18), (ii) murine fibroblasts (which have no endogenous murine CDlla/CD18 
expression), and (iii) murine fibroblasts, which have been stably transfected with a h u m a n CDlla gene. In 
murine lymphoblasts, h u m a n C D 1 8 was expressed on the cell surface as a heterodimer with murine CDlla. 
Cell-surface expression of h u m a n C D 1 8 had no apparent effect on the level of endogenous murine CDlla/CD18 
expression. Immunoprecipitation of cell-surface labeled proteins in murine lymphoblasts with a h u m a n C D 1 8 
specific antibody co-precipitated murine CDlla. H u m a n C D 1 8 can be detected by immunochemistry in the 
cytoplasm of fibroblasts infected with C D 1 8 encoding retrovirus, but coexpression with CDlla is required for 
cell-surface expression of either subunit in fibroblasts. These studies suggest that h u m a n C D 1 8 will form a 
heterodimer with murine CDlla and that h u m a n C D 1 8 is not expressed on the cell surface of cells not expressing 
CD11. This provides the basis for the development of a murine hematopoietic stem cell gene replacement 
therapy model for the treatment of L A D . 
OVERVIEW SUMMARY 
In developing human gene therapy clinical protocols, it is 
helpful to have an animal model that mimics the human 
disease to be treated. A natural animal model for leukocyte 
adhesion deficiency (LAD) does not exist. Krauss etal. have 
developed a clever strategy for producing a mouse model for 
L A D gene therapy. 
INTRODUCTION 
LEUKOCYTE ADHESION deficiency (LAD) is a rare, autoso-
mal recessive disorder characterized by recurrent infections 
and absence of leukocyte adherence to a variety of surfaces 
(Anderson and Springer, 1987; Todd and Freyer, 1988). Normal 
leukocyte adhesion is mediated by a series of heterodimeric, 
transmembrane glycoproteins composed of a common fi-subunit 
C D 18 and one of three unique a-subunits CD1 la, CD1 lb, and 
CDllc (Springer et aL, 1984). In L A D patients, a defective 
CD18 gene results in absent or decreased cell-surface expression 
of C D 11 /CD 18 dimers (Springer ef aL, 1984). Severely affected 
patients (patients with CD11/CD18 levels of less than 1% of 
normal level) succcumb to severe infections in early childhood 
(Anderson et al., 1985). The disorder is characterized by 
peripheral leukocytosis, but virtually no pus formation at the site 
of infection, indicating that deficient CD11/CD18 neutrophils 
may not pr perly migrate to areas of active infection (Anderson 
etal., 1985). Bone marrow transplantation is curative, suggest-
ing that reconstitution of C D 18 expression in the hematopoietic 
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stem cell may be therapeutic (Le Deist et al., 1989). 
W e and others have shown that retroviral mediated transduc-
tion of a human C D 18 gene can complement the defect in a 
ly mphoblast cell line derived from a patient with a L A D (Back et 
al., 1990; Wilson etal., 1990). Because the defect is manifested 
in both lymphocytes and granulocytes, the hematopoietic stem 
cell is the appropriate cell to correct in this disorder (Todd and 
Freyer, 1988). W e ultimately seek to develop a murine bone 
marrow transplant model of a stem cell gene replacement 
therapy of LAD. 
Our strategy for developing an in vivo animal model of L A D 
gene therapy is to introduce a normal human C D 18 gene into 
bone marrow of a wild-type mouse, and reconstitute a syngeneic 
recipient with the vector-transduced bone marrow. An important 
feature of this model is a method for detecting human C D 18 
expression in murine leukocytes. In addition, the potential for 
ectopic C D 18 cell-surface expression needs to be addressed. 
In this report, we use a murine T-lymphoblast cell line (which 
normally expresses murine CD1 la/CD 18) to develop a specific 
and sensitive assay for detecting human C D 18 on the cell surface 
of murine leukocytes. The assay is based on the hypothesis that 
human C D 18 will form chimeric heterodimers with murine 
CD11 on the surface and that the human subunit can be detected 
with human specific monoclonal antibodies (mAbs). Additional 
experiments were aimed at studying human C D 18 expression in 
nonhematopoietic cells in the presence or absence of CD11 
expression. 
MATERIALS AND METHODS 
Cell Lines: BW5147 was derived from a murine T-cell 
lymphoma (Ralph, 1973) and obtained from the American Type 
Culture Collection (ATCC; Rockville, M D ) . ̂ cre (Danos and 
Mulligan, 1988) and NIH-3T3 cells were obtained from R. 
Mulligan (Whitehead Institute, Boston, M A ) . All lymphoblast 
populations were grown in D M E M (high glucose) supplemented 
with 1 0 % fetal bovine serum (GIBCO, Grand Island, N Y ) and 
penicillin/streptomycin, ̂ cre and NIH-3T3 cells were grown in 
D M E M (high glucose) supplemented with 1 0 % calf serum and 
penicillin/streptomycin. 
NIH-3T3 Cell Line That Expresses Human CDlla: A vector 
that expresses human CD1 la was constructed. Sequences span-
ning the entire coding region of human CD1 la were excised on 
a Hind III to Sph I fragment of the previously described c D N A 
clone, pLAR (provided by Dr. T. Springer, Boston, M A ; Larson 
et al., 1989). The Sph I site was converted to an Xba I site with 
synthetic linkers and the modified fragment was ligated with a 
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FIG. 1. A. Structure of pEMO-CD18 retroviral vector. LTR, Long terminal repeat sequences; K, Kpn I. B. D N A blot analysis. 
Total cellular D N A (10 u,g) was restricted with Kpn I and analyzed as described in Materials and Methods. D N A (10 (jug) from 
untransduced BW5147 cells was analyzed alone (CON) and with the equivalent of one copy of provirus/cell (7.5 pg) of pEMO-CD18 
plasmid (CON + 1 copy). Analyses were also performed with D N A from BW5147 cells after co-cultivation prior to F A C S 
(Pre-Sort), and after one round (Post-Sort #1) and two rounds (Post-Sort #2) of FACS. Molecular weight markers are listed along 
the right border. C. R N A blot analysis. Total cellular R N A (10 u-g) was analyzed as described in Materials and Methods. R N A was 
isolated from untransduced BW5147 cells (CON) and transduced BW5147 cells prior to F A C S (Pre-Sort), and after one round 
(Post-Sort #1) and two rounds (Post-Sort #2) of FACS. The filter was initially probed with a radiolabeled C D 18 c D N A fragment 
(upper radiograph). The band at 3 kb is common to all lanes and represents hybridization to the endogenous transcript. The filter was 
stripped and reprobed with the radiolabeled fragment from human 7-actin gene (lower audioradiograph; Wilson et al., 1988). 
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Hind Ill/Xba I fragment from the expression vector called pBA. 
This vector contains a promoter derived from the chicken 
P-actin gene (-274 to + 1 bp; Quitschke et al., 1989) and 
polyadenylation sequences from bovine growth hormone. This 
plasmid, called pBA-hCDlla (10 p.g) was mixed with 
pSV2Neo and transfected into NIH-3T3 cells (Danos and Mul-
ligan, 1988). The cells were allowed to come to confluence and 
then split into D M E M containing G418 (1 mg/ml total concen-
tration). Fifteen individual clones of G418-resistant cells were 
selected and scaled up into duplicate 10-cm plates; cells from 
one plate were cryopreserved and the other was used to make 
R N A . The individual clones were screened for content of human 
C D 1 la R N A , and the clone that produced the highest levels of 
CDlla R N A was scaled up, and transduced with the C D 18 
encoding retroviral vector as described for NIH-3T3 cells. 
Retroviral Vectors and Transduction: The retroviral vector 
p E M O - C D 1 8 has been described (Wilson et al., 1990). A ^cre 
packaging cell line was produced from this vector as follows: 
p E M O - C D 1 8 plasmid D N A (15 |xg) was co-transfected with 
pS V 2 N E O (1.5 |xg) as described by Danos and Mulligan (1988). 
After the transfected populations of cells had come to conflu-
ence, they were split into medium containing G418 (1 mg/ml 
total concentration). Twenty-five individual G418-resistant col-
onies were isolated and cryopreserved. Tissue culture superna-
tant from each of the expanded clones was harvested and the titer 
of virus in each supernatant was estimated as follows. NIH-3T3 
cells at 106 cells/10-cm plate were transduced with retroviral 
vector supernatant in the presence of 8 |xg/ml of Polybrene for 
12-16 hr. W h e n the monolayers were confluent, high-molecu-
lar-weight D N A was isolated, restricted with Kpn I, and assayed 
by D N A blot analysis using human C D 18 as a probe. This 
permits an analysis of proviral integrity and estimate of proviral 
abundance in the transduced cells. The clone capable of produc-
ing the highest titer of vector, as measured by the most abundant 
quantity of unrearranged provirus in the transduced NIH-3T3 
cells, was used in subsequent experiments. 
The recombinant retroviral vector producing clone (initial 
density 1.2 x 106 cells/10-cm plate) was cocultivated with the 
murine lymphoblast B W 5 1 4 7 (5 x 106 cells) in D M E M con-
taining fetal calf serum (10%), penicillin/streptomycin, and 
Polybrene (8 M-g/ml) for 2 days. Following the co-cultivation, 
the lymphoblasts were gently removed by serially plating the 
cells into two tissue cultures flasks (Falcon) for a total of 48 hr. 
The lymphoblasts were then expanded and analyzed. 
Immunochemistry: Retroviral vector-transduced and -trans-
fected NIH-3T3 fibroblasts were analyzed for expression of 
human C D 1 la and C D 18 by immunocytochemistry. The trans-
duced cells were plated onto glass slides, fixed in ethanol for 10 
min at 4CC, incubated with a m A b (either anti-human-CDlla 
[TS1/22], or anti-human-CD 18 [TS1/18]), washed, and then 
secondarily stained with goat anti-murine immunoglobulin-
biotin conjugate. The slides were then washed and stained with 
a streptavidin-horseradish peroxidase conjugate and developed 
with 9-AEC purchased from Zymed labs (San Francisco, C A ) . 
TS1/18 and TS1/22 used in this experiment were obtained from 
the A T C C and used as neat tissue culture supernatants (Sanchez-
Madrid et al., 1982). 
Flow Cytometric Analysis: Rat anti-murine CDlla (M17/ 
4.4.11.9; Sanchez-Madrid et al., 1983), rat anti-murine C D 1 8 
(M18-2.a.l2.7; Sanchez-Madrid et al, 1983), and the murine 
control antibody [rat anti-murine CDllb(Ml/70.15.11.5.HL; 
Springer et al., 1978)] were from the A T C C and were used as 
neat tissue culture supernatants. The murine anti-human C D 18 
antibody (IB4) was kindly provided in a purified form by Dr. S. 
Wright (Rockefeller University, N e w York, N Y ; Wright et al., 
1983). Murine anti-human control antibodies M45q and P181 
were purified from ascites (Biondi et al., 1984). Single-color 
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FIG. 2. Flow cytometric analysis of transduced lymphoblasts. 
BW5147 lymphoblasts were analyzed for cell-surface expres-
sion of human C D 18 as described in Materials and Methods. 
Analyses included B W 5 1 4 7 lymphoblasts that were mock in-
fected (A) or infected with virus and analyzed directly (B), after 
the first F A C S (C) and after the second F A C S (D). Data are 
presented as individual histograms of cell frequency versus 
immunofluorescence (log scale). The control antibody is shown 
shaded and the anti-human C D 18 antibody is shown unshaded. 
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immunofluorescence was performed as described (Wilson etal., 
1990). 
For two-color immunofluorescence, IB4 and M45q antibod-
ies were biotinylated by standard procedures (Updyke and 
Nicolson, 1986), purified, and used as biotin conjugates. Cells 
(106/ml) were incubated with a rat anti-murine epitope antibody 
and a mouse anti-human epitope antibody, and subsequently 
stained with a goat anti-rat phycoerythrin (Southern Biotechnol-
ogy, Birmingham, AL) and streptavidin-FITC. The cells were 
then fixed in 1 % formaldehyde in phosphate-buffered saline 
(PBS) and analyzed for red and green fluorescence on a Coulter 
EPICS flow cytometer. 
D N A and R N A Analysis: Total cellular D N A was isolated, 
restricted with Kpn I, transferred to a nylon filter and hybridized 
to a human CD18 probe as described previously (Wilson et al., 
1990). Total cellular R N A was isolated, fractionated in a 
formaldehyde/agarose gel, and subjected to R N A blot analysis 
using a human C D 18 c D N A probe as described previously 
(Wilson etal., 1990). 
Immunoprecipitation: Lymphoblasts (60 x 106) were sur-
face-labeled with l25I (Amersham, Arlington Heights, IL) by 
the lactoperoxidase method (Kessler, 1981). Cells were washed 
free of excess ,25I in PBS, and lysed in NP-40 lysis buffer con-
sisting of 1 % NP-40, 1 m M PMSF, 1 u.g/ml each of leupeptin, 
pepstatin A, antipain, and chymostatin, 10 m M iodoacetamide, 
1 m M E D T A , 150 m M NaCl, and 10 m M Tris pH 8.0 in distilled 
water (all reagents from Sigma, St. Louis, M O ) . The lysate was 
centrifuged in a microfuge and the supernatant was collected and 
precleared three times with 50 |xl of Staph A (Bethesda Research 
Laboratories, Gaithersberg, M D ) . The lysate was then subjected 
to solid-phase immunoprecipitation (Tamura et al., 1984). 
Antibody (100 |xg/ml) made to mouse immunoglobulin (for 
human C D 18 immunoprecipitation) or rat immunoglobulin (for 
murine C D 18 immunoprecipitation) was adhered to a polyvinyl 
chloride microtiter plate overnight at 4°C. Excess antibody was 
removed with PBS, and a 1 : 10 dilution of ascites (anti-human 
CD18-TS1/18, provided by T. Springer, control antibody-
pl81), or neat tissue culture supernatant (anti-murine CD18-
M18/2.a.l2.7, control antibody-Ml/70.15.11.5), was then al-
lowed to bind for 4 hr at 4°C. Wells were washed, blocked with 
1 % fetal calf serum in PBS, and incubated with l25I lysates at 
4°C overnight. The lysates were carefully removed, the wells 
were washed, and the bound antigen was solubilized in SDS 
containing sample buffer. The samples were denatured by 
heating to 100°C for 5 min and then run on a nonreducing 8 % 
SDS-PAGE. The gel was dryed onto filter paper and exposed to 
film. 
RESULTS 
Human CD18 transducing retroviruses 
An ecotropic retroviral vector producer cell line was made 
with C D 18 expressing retroviral vector used in our previous 
human complementation experiments (Wilson et al., 1990). The 
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FIG. 3. Two-color flow cytometric analysis of untransduced and transduced, Post-Sort # 2 B W 5 1 4 7 cells. Cells were stained 
simultaneously with a biotin-conjugate formed with anti-human C D 18 m A b (IB4) or control m A b (M45q) together with one of the 
following rat mAbs: anti-murine C D 1 la, anti-murine CD18, or a control anti-murine m A b (Con Ab). Staining and flow cytometry 
are described in Materials and Methods. Red fluorescence is measured on the y axis and green fluorescence is measured on the x axis. 
Panels represent either untransduced cells or transduced cells (Post-Sort #2) stained with m A b s directed against the various murine 
epitopes listed above. 
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vector (called pEMO-CD18, depicted in Fig. 1A) contains a 
single LTR-based transcriptional unit that produces an unproc-
essed genomic transcript responsible for both transduction of 
CD18 and passage of the vector. Supernatants from 25 individ-
ual retroviral vector-producing cell lines were screened for titer 
of vector. Unrearranged proviral sequences, as measured by 
D N A blot analysis, were most abundant in NIH-3T3 cells 
infected with virus from clone 67-11 (0.1 proviral copies/cell, 
data not shown). 
Human CD18 expression in murine lymphoblasts 
Murine lymphoblasts were cocultivated with the retroviral 
vector producing cells for 2 days and subsequently expanded in 
culture. The lymphoblasts were analyzed by flow cytometry 
using an m A b specific for a human C D 18 epitope. A small 
population of fluorescent cells (approximately 1%) was noted in 
the lymphoblast cultures after cocultivation (Fig. 2B). This 
population of lymphoblasts was subjected to two sequential 
cycles of fluorescent activated cell sorting (FACS) using the 
human specific C D 18 m A b in order to enrich for transduced 
cells. After two sterile sorts, a population of lymphoblasts that 
expressed high levels of human C D 18 was obtained (Fig. 
2C,D). 
Populations of murine lymphoblasts that had been retrovirally 
transduced with a human C D 18 gene and sorted for cell-surface 
expression of human C D 18 were characterized for proviral D N A 
(Fig. IB) and R N A (Fig. 1C). Molecular analyses were specif-
ically performed on control lymphoblasts, and transduced lym-
phoblasts prior to F A C S (Pre-Sort) and after one round (Post-
Sort # 1) and two rounds (Post-Sort #2) of FACS. Proviral D N A 
was undetectable (<0.1 copies/cell) in the presort population of 
transduced lymphoblasts (Fig. IB, lane Pre-Sort). Enrichment 
of this population of cells for cell-surface expression of human 
C D 18 was associated with the appearance and increase of 
unrearranged proviral D N A to approximately 1 proviral copy/ 
cell after two sterile sorts (Fig. 1B, lane Post-Sort #2). Proviral-
derived C D 18 R N A was detected after cocultivation in the 
presort population (Fig. 1C, lane Pre-Sort). The relative abun-
dance of this transcript increased dramatically as the cells were 
enriched for cell-surface expression of human C D 18 (Fig. 1C, 
lane Post-Sort #2). The population of cells obtained after two 
sterile sorts with human C D 18 m A b were subjected to further 
biochemical analyses of human C D 18 protein expression. 
Murine lymphoblasts (untransduced and Post Sort #2) were 
analyzed by two-color flow cytometry for the coexpression of 
human C D 1 8 with murine CD18 and murine CDlla (Fig. 3). 
The untransduced murine lymphoblasts uniformly expressed 
high levels of endogenous CD18 and CDlla (Fig. 3C,E). 
Expression of human C D 18 in the transduced Post-Sort # 2 
population of cells had no apparent effect on the level of 
endogenous C D 1 la and C D 18 protein (Fig. 3J,L). 
It has been suggested that C D 18 must associate with a CD11 
subunit to be transported to, and positioned in, the plasma 
membrane (Marlin et al., 1986). W e proposed, therefore, that 
human C D 18 must be complexed with murine C D 11 a on the cell 
surface of the Post-Sort # 2 murine lymphoblasts. To prove this 
hypothesis, we performed the following immunoprecipitation 
experiments. Extracellular domains of membrane proteins were 
radiolabeled with 125I and C D 11/CD 18 complexes were isolated 
by immunoprecipitation with subunit and species-specific m A b 
(Fig. 4). Immunoprecipitation of extracts from untransduced 
cells revealed (i) no detectable bands over background when a 
human specific CD18 m A b was used (Fig. 4, lane A ) , and 2) 
bands that migrated with apparent molecular weights similar to 
murine C D 18 (95 kD) and murine CDlla (180 kD) when a 
murine-specific m A b was used (Fig. 4, lane B). Immunoprecip-
itation of extracts from transduced Post-Sort # 2 cells with 
antibody to murine C D 18 again demonstrated the endogenous 
CD18 and CDlla bands (Fig. 4, lane F). Immunoprecipitation 
of these extracts with a human-specific C D 18 m A b produced a 
band of 100 k D representing human C D 18 and a band of 180 k D 
representing murine CDlla (Fig. 4, lane E). The isolation of 
murine CD1 la with m A b to human C D 18 suggests that the two 
glycoproteins are in close association with one another in the 
plasma membrane. The anomolous electrophoretic migration of 
human C D 18 as compared to murine C D 18 has been described 
previously (Sanchez-Madrid et al., 1982). 
Human CD18 expression in murine fibroblasts 
We next studied the expression of human CD 18 in the 
nonhematopoietic cell line, NIH-3T3 fibroblasts. Immunocy-
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FIG. 4. Immunoprecipitation of 125I surface-labeled proteins. 
Proteins from untransduced and Post-Sort # 2 transduced 
BW5147 lymphoblasts were surface labeled and immunoprecip-
itated with anti-CD 18 m A b or control m A b as described. H 
represents mAbs to human C D 18 epitopes (including an isotype 
negative control) while M represents m A b s to murine C D 18 
epitopes (including an isotype negative control). Molecular 
weight standards in kilodaltons are noted along the right border. 
Lysates of untransduced cells were precipitated with anti-CD 18 
to human (A) or mouse (B) or control m A b for human (C) or 
mouse (D). Lysates of transduced cells were precipitated with 
anti-CD 18 to human (E) or mouse (F) or control m A b for human 
(G) or mouse (H). 
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tochemical analysis of NIH-3T3 cells transduced with C D 18 
retroviral vector revealed a subpopulation of cells with signifi-
cant cytoplasmic staining (Fig. 5B). The efficiency of gene 
transfer estimated by immunocytochemistry (approximately 
1 0 % of all cells) was in good agreement with the estimate based 
on D N A blot analysis (0.1 proviral copies/cell). Flow cytomet-
ric analysis of this same population of cells with anit-human 
C D 18 m A b failed to detect cell-surface fluorescence over 
background (Fig. 6B), suggesting that the human CD18 protein 
is not expressed on the plasma membrane. One explanation for 
these observations is that intracellular formation of a C D 11/ 
C D 18 heterodimer is necessary for efficient transport to the 
plasma membrane. 
This hypothesis was directly tested by studying human C D 18 
expression in a clone of NIH-3T3 cells that express human 
CDlla. NIH-3T3 cells transfected with a CDlla expression 
vector demonstrate abundant intracellular CDlla protein by 
immunocytochemistry (Fig. 5C) but no cell-surface CDlla 
protein by flow cytometry (Fig. 6C). However, coexpression of 
CD1 la (Fig. 5E) and CD18 (Fig. 5F) in C D 1 la-expressing cells 
transduced with the C D 18 retroviral vector resulted in cell-
surface expression of both subunits (Fig. 6E,F). 
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FIG. 5. Immunochemistry of murine fibroblasts. Immunochemistry was performed as described in Materials and Methods. 
Anti-human C D 18 antibody is TS1 /18, and the anti-human C D 11 a antibody is TS1 /22. Cells were counterstained with hematoxylin, 
and photomicrographs were taken with a Nikon microscope (original magnification, 400X). Panels represent NIH-3T3 cells 
transduced with a CD18-encoding retrovirus and stained with anti-CDlla (A) or anti-CD18 (B); C D 1 la-expressing cell line 
(NIH-3T3/CD1 la) stained with anti-CD 1 la (C) or anti-CD 18 (D); and C D 1 la-expressing NIH-3T3 cell line transduced with the 
CD18-encoding retrovirus (NIH-3T3/CDlla/CD18) stained with anti-CDlla (E) or anti-CD 18 (F). 
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FIG. 6. Flow cytometric analysis of NIH-3T3 cells. Cells 
were stained as described in Materials and Methods. Panels 
represent a control antibody (shaded) over the antibody of 
interest (unshaded). Data are presented as individual histograms 
of cell frequency versus immunofluorescence (log scale). Anti-
human C D 18 antibody is T S 1/18; anti-human C D 1 la antibody 
is TS1/22. Panels are representative of the following cells: 
NIH-3T3 cells transduced with the CD18-encoding retrovirus 
and stained with anti-CDlla (A) or anti-CD18 (B); C D 1 la-
expressing cell line (NIH-3T3/CD1 la) stained with anti-CD 1 la 
(C) or anti-CD 18 (D); and C D 1 la-expressing cell line trans-
duced with CD18-encoding retrovirus and stained with anti-
CDlla (E) or anti-CD 18 (F). 
DISCUSSION 
LAD has many features that make it an excellent candidate for 
somatic gene therapy. It is an autosomal recessive disease 
caused by a defect in the gene that encodes C D 18. W e showed 
previously that the introduction of a normal C D 18 gene into 
LAD-derived lymphocytes by retroviral-mediated gene transfer 
was sufficient to reconstitute normal adhesion-related functions 
(Wilson et aL, 1990). The relative success of allogeneic bone 
marrow transplantation suggests that the appropriate target cell 
for gene transfer is the hematopoietic stem cell (LeDeist etal., 
1989). Gene therapy, therefore, could be by a modification of 
autologous bone marrow transplantation. Finally, residual ex-
pression of C D 11 a/CD 18 protein in homozygous-deficient pa-
tients is associated with a less severe phenotype, suggesting that 
partial genetic reconstition may be therapeutic (Anderson etaL, 
1985). 
To better assess the therapeutic potential and risks of gene 
therapy for L A D , it is important to develop an in vivo animal 
model of human C D 18 gene transfer. This would best be 
accomplished in the setting of an animal model of C D 18 
deficiency. Whereas L A D has been observed in a dog (Giger et 
aL, 1987), since deceased, and in Holstein cattle (Kehrli et al., 
1990), neither animal offers a practical model for the preclinical 
testing of bone marrow gene replacement therapies. As an 
alternate, we propose a murine model in which a human C D 18 
gene is retrovirally transduced into bone marrow from a wild-
type C3H/HeJ mouse, and lethally irradiated syngeneic recipi-
ents are reconstituted with the genetically modified bone mar-
row. 
For this to be a valid model, it is important that human C D 18 
is appropriately expressed in murine leukocytes. Under normal 
conditions, the nascent C D 18 peptide associates with C D 11 
subunit in the endoplasmic reticulum and the heterodimer is 
transported to secretory granules as well as the plasma mem-
brane. CD11/CD18 heterodimer formation is a prerequisite for 
normal processing. In this study, we tested the hypothesis that 
retroviral-transduced human C D 18 will form heterodimers with 
murine C D 1 la in a murine T-lymphoblast cell line, and that the 
chimeric heterodimer will be appropriately transported to the 
cell surface. Transduction of a human C D 18 gene into murine 
lymphoblasts, in fact, resulted in high-level expression of the 
human subunit on the cell surface. Immunoprecipitation exper-
iments suggested that, in this context, human C D 18 was physi-
cally associated with murine CDlla, thereby confirming our 
original hypothesis. These results are in agremeent with previ-
ous studies of Springer, who analyzed CD11/CD18 expression 
in murine-human somatic cell hybrids (Marlin et aL, 1986). In 
addition, we demonstrated that in fibroblast cell lines, both 
CDlla and C D 18 expression are required for cell-surface 
C D 11 a/CD 18 expression, but each protein could be detected 
singly by immunocytochemistry in the cytoplasm of cells that 
only express the transcript for one of the proteins. This suggests 
that C D 18 cell-surface expression in vivo may not occur in cells 
that do not contain CD11 transcript. 
Our results support the utility of the proposed in vivo animal 
model for studying human C D 18 gene transfer in the context of 
a normal murine background. One advantage of the model is that 
transgene expression can be quantitatively measured in a limited 
number of hematopoietic cells by flow cytometry using human-
specific C D 18 mAbs. Two-color flow cytometry affords the 
opportunity to study transgene expression in virtually any 
subpopulation of leukocytes. The spectrum and resolution of 
these analyses are limited only by the availability and specificity 
of m A b s to leukocyte antigens. Finally, the coexpression of 
human CD18/murine C D 11 heterodimers with murine C D 18/ 
murine C D 11 heterodimers in the same cells will provide an 
opportunity to assess the level and regulation of transgene 
expression relative to endogenous gene expression. 
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